Navigation Links
2013 Pharmaceutical Intellectual Property Forum is Coming in November
Date:9/6/2013

SHANGHAI, Sept. 6, 2013 /PRNewswire/ -- From the labor-intensive "Made in China" to knowledge-based "Created in China," China has embarked on an innovative journey to transform itself. However, to realize the transformation, there is a prerequisite, that is the Intellectual Property Right (IPR) protection. The tracker of emerging technologies says China is poised to surpass Japan as the second-largest spender on biomedical R&D, behind the U.S., as it sets far-ranging targets for new drug development as part of its 12th Five-Year Plan. The country's total R&D investments reached a cumulative $160 billion last year and are said to be paying off with exponential increases in pharmaceutical-related patent filings, according to a report issued by Lux Research. Unlike patents in other industries, pharmaceutical patents cover products that take a very long time to develop. It takes 10-15 years on average to develop a new medicine from the earliest stages of compound discovery to final approval. IP management has become the most important protection tool for R&D innovation and patent has been proved to be the primary driver of Pharma & Biotech corporate earnings.

(Photo: http://www.prnasia.com/sa/2013/09/05/20130905170955182665.html )

Organized by CPhI and UBM Conferences, 2013 Pharmaceutical Intellectual Property Forum is to be held on 27-28 November in Shanghai, China. This conference aims to provide a platform to facilitate exchange of experience, and encourage more cooperation between Pharmaceutical & Biotech Companies, Law firms and IP Agencies. You will walk away with fresh insights, tactics and tools to apply for patents, strategize your litigation techniques and remain competitive in today's constantly changing patent landscape. Hear from experts, meet potential collaborators and gather insights to re-align your own IP strategy - only at PIPF! To download full agenda, please click to: www.pharmaip-forum.com.

Conference Highlights

  • Hearing from Pfizer, Bayer, Merck, GSK, Abbott on Global and Regional Pharma IP Scene
  • Navigating the Regulatory Landscape in Key Countries
  • Resolving Patent Regime, Patent Cliff and Patent Licensing Issues and Learning Solutions for your Top Challenges in the Interactive and Focused Panel Discussions
  • Identifying Future Opportunities in Generics and Biosimilars
  • A Wide Range of Cutting-Edge Case Studies from Leading IPR Experts
  • Agenda At A Glance  

    November 27

    China IP Regulation UpdatesInternational Perspectives on IP RightsPatent Strategies for Pharmaceutical Products 

    November 28

     

    Spotlight: Generics and Bio-MedicinePractical Litigation CasesPractices of IP ManagementIf you have any questions, please call +86-21-61573930 or email to askconference@ubm.com.

    Media Contact Ms. Tracy Cui
    Tel: +86-21-6157 3919
    Fax: +86-21-6157 7299
    Email: tracy.cui@ubm.com


    '/>"/>
    SOURCE CPhI Conferences
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Buyout Alert -- Astex Pharmaceuticals -- Law Firm Seeks Higher Price For Shareholders
    2. Auxilium Pharmaceuticals, Inc. To Present At The Stifel Nicolaus Healthcare Conference
    3. Isis Pharmaceuticals to Present at the 2013 Stifel Healthcare Conference
    4. Questcor Pharmaceuticals to Participate in Morgan Stanley Global Healthcare Conference
    5. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
    6. Pharmaceutical and Medical Device Patent Portfolio Acquisition Opportunities from ICAP Patent Brokerage
    7. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
    8. David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer
    9. Isis Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
    10. Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013
    11. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
    (Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
    (Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
    Breaking Medicine Technology:
    (Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
    (Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
    (Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
    (Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
    (Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
    Breaking Medicine News(10 mins):